Citation: | WANG Jinyu, LI Guoping. Mechanism of circ0006152/miR-557/Wnt3a signal axis in the genesis and development of non-small cell lung cancer A549 cells[J]. Chinese Journal of General Practice, 2024, 22(3): 418-423. doi: 10.16766/j.cnki.issn.1674-4152.003416 |
[1] |
LI L, SUN D, LI X, et al. Identification of key circRNAs in non-small cell lung cancer[J]. Am J Med Sci, 2021, 361(1): 98-105. doi: 10.1016/j.amjms.2020.08.008
|
[2] |
REN Y, SHE Y, TANG H, et al. Prognostic evaluation of the proposed residual tumor classification in a Chinese non-small cell lung cancer population[J]. J Surg Oncol, 2022, 125(6): 1061-1070. doi: 10.1002/jso.26810
|
[3] |
ZHANG Q, KANG L K, LI X Y, et al. Bioinformatics analysis predicts hsa_circ_0026337/miR-197-3p as a potential oncogenic ceRNA network for non-small cell lung cancers[J]. Anticancer Agents Med Chem, 2022, 22(5): 874-886. doi: 10.2174/1871520621666210712090721
|
[4] |
YANG Y, SUN K K, SHEN X J, et al. MiR-557 inhibits the proliferation and invasion of pancreatic cancer cells by targeting EGFR[J]. Int J Clin Exp Pathol, 2019, 12(4): 1333-1341.
|
[5] |
BORA Y, TRIKALINOS N A, Vincent M, et al. Real-world use and survival outcomes of immune checkpoint inhibitors in older adults with non-small cell lung cancer[J]. Cancer, 2020, 126(5): 978-985. doi: 10.1002/cncr.32624
|
[6] |
谢忠海, 李鸿伟, 臧金, 等. 非小细胞肺癌根治术患者术后临床特征调查及预后影响因素分析[J]. 中华全科医学, 2022, 20(11): 1860-1862. doi: 10.16766/j.cnki.issn.1674-4152.002720
|
[7] |
LI M, LIU Y, JIANG X, et al. Inhibition of miR-144-3p exacerbates non-small cell lung cancer progression by targeting CEP55[J]. Acta Biochimit Biophys Sin, 2021, 53(10): 1398-1407. doi: 10.1093/abbs/gmab118
|
[8] |
BALENDRAN P, PRICE M, TIWARI A, et al. Impact of PD1 and PDL1 immunotherapy on non-small cell lung cancer outcomes: a systematic review[J]. Thorax, 2022, 68(11): 394-424.
|
[9] |
侯岩君, 田进海, 王立斌, 等. CircRNA hsa_circ_0044569在肺癌诊断中的价值[J]. 肿瘤防治研究, 2021, 48(12): 1061-1065. doi: 10.3971/j.issn.1000-8578.2021.21.0488
|
[10] |
孔卓, 陈发坤, 夏彩霞, 等. Circ_0000212靶向miR-637调控肺癌H1299细胞的增殖、凋亡和放射敏感性[J]. 标记免疫分析与临床, 2022, 29(6): 1007-1014. https://www.cnki.com.cn/Article/CJFDTOTAL-BJMY202206022.htm
|
[11] |
黎亮, 蔡仁中, 李高, 等. 非小细胞肺癌组织的环状RNAcirc_0080220水平和临床意义[J]. 临床肿瘤学杂志, 2021, 26(6): 537-540. https://www.cnki.com.cn/Article/CJFDTOTAL-LCZL202106008.htm
|
[12] |
许俊, 朱承莹, 王德钧. circ_0015756通过调控miR-515-5p/HMGB3轴影响肺癌细胞增殖、凋亡和迁移[J]. 中国细胞生物学学报, 2021, 43(7): 1446-1454. https://www.cnki.com.cn/Article/CJFDTOTAL-XBZZ202107016.htm
|
[13] |
陈绪林, 姜宇, 赵艳, 等. 原发性肝癌组织中miR-557的表达及其与预后的关系[J]. 国际消化病杂志, 2021, 41(4): 313-316. https://www.cnki.com.cn/Article/CJFDTOTAL-GWXH202104020.htm
|
[14] |
ZHANG Y, ZHANG R, XI D, et al. EFNB2 acts as the target of miR-557 to facilitate cell proliferation, migration and invasion in pancreatic ductal adenocarcinoma by bioinformatics analysis and verification[J]. Am J Transl Res, 2018, 10(11): 3514-3528.
|
[15] |
高志强, 李丁洋, 刘兆臣, 等. 环状RNA0007841靶向miR-557影响肝癌MHCC97H细胞增殖、迁移和侵袭的机制[J]. 中华实验外科杂志, 2021, 38(7): 1275-1279.
|
[16] |
赛文莉, 姚敏, 郑文杰, 等. 癌组织Wnt3a异常表达及其靶向干预对肝癌的抑制作用[J]. 中华肝脏病杂志, 2019, 27(11): 866-871.
|
[17] |
刘晶晶, 刘海娟, 王荣. Wnt3a对子宫内膜癌细胞转移的影响及其分子机制[J]. 山东医药, 2020, 60(29): 23-27.
|